文献速递肥胖与代谢综合征糖尿病

孕产妇肥胖、妊娠糖尿病与高血压性妊娠障碍的纵向代谢特征分析

Longitudinal Metabolic Profiling of Maternal Obesity, Gestational Diabetes, and Hypertensive Pregnancy Disorders.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究对PREDO和RADIEL两个队列共741名孕妇进行二次分析,在孕13、20、28周用核磁共振检测225项代谢指标。结果显示肥胖孕妇在三个时间点均呈现更差的代谢谱,且孕期代谢变化幅度小于正常体重孕妇;妊娠糖尿病、子痫前期和慢性高血压与肥胖有相似的代谢改变,但调整BMI后多数关联不再显著。

要点

  • 肥胖孕妇在孕早期即出现代谢紊乱,且整个孕期代谢变化幅度小于正常体重者。
  • 妊娠糖尿病、子痫前期和慢性高血压的代谢改变与肥胖相似,提示共享代谢起源。
  • 调整BMI后,妊娠糖尿病和高血压疾病与代谢指标的多数关联不再显著。

核心结论

  • 肥胖孕妇孕期代谢变化较小,且孕早期已存在代谢紊乱。
  • 肥胖与妊娠期疾病的代谢改变相似,提示共享代谢起源。

研究设计与样本

  • 对PREDO和RADIEL两个研究队列的二次分析,共纳入741名孕妇。
  • 在孕13、20、28周(中位数)采集血样,用核磁共振检测225项代谢指标。

主要发现

  • 肥胖(BMI≥30kg/m2)孕妇在三个时间点均较正常体重(BMI 18.5-24.99 kg/m2)孕妇有更高水平的多数极低密度脂蛋白相关指标、许多脂肪酸和多数氨基酸,代谢谱更差。
  • 肥胖孕妇孕期多数代谢指标的变化幅度小于正常体重孕妇。
  • 妊娠糖尿病、子痫前期和慢性高血压与肥胖有相似的代谢改变。
  • 调整妊娠糖尿病和高血压疾病后,肥胖的关联仍存在;但调整BMI和其他妊娠疾病后,妊娠糖尿病和高血压疾病的多数关联不再显著。

关键数值与推荐

  • 肥胖定义为BMI≥30kg/m2,正常体重定义为BMI 18.5-24.99 kg/m2。
  • 血样采集时间中位数分别为孕13周(IQR 12.4-13.7)、20周(IQR 19.3-23.0)和28周(IQR 27.0-35.0)。
  • 代谢指标共225项,通过核磁共振检测。

临床怎么用

  • 对肥胖孕妇应关注孕早期代谢紊乱,并加强孕期代谢监测。
  • 妊娠糖尿病和高血压疾病的代谢异常部分由肥胖介导,管理时应重视体重因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Comprehensive assessment of metabolism in maternal obesity and pregnancy disorders can provide information about the shared maternal-fetal milieu and give insight into both maternal long-term health and intergenerational transmission of disease burden. OBJECTIVE: To assess levels, profiles, and change in the levels of metabolic measures during pregnancies complicated by obesity, gestational diabetes (GDM), or hypertensive disorders. DESIGN, SETTING AND PARTICIPANTS: A secondary analysis of 2 study cohorts, PREDO and RADIEL, including 741 pregnant women. MAIN OUTCOME MEASURES: We assessed 225 metabolic measures by nuclear magnetic resonance in blood samples collected at median 13 [interquartile range (IQR) 12.4-13.7], 20 (IQR 19.3-23.0), and 28 (27.0-35.0) weeks of gestation. RESULTS: Across all 3 time points women with obesity [body mass index (BMI) ≥ 30kg/m2] in comparison to normal weight (BMI 18.5-24.99 kg/m2) had significantly higher levels of most very-low-density lipoprotein-related measures, many fatty and most amino acids, and more adverse metabolic profiles. The change in the levels of most metabolic measures during pregnancy was smaller in obese than in normal weight women. GDM, preeclampsia, and chronic hypertension were associated with metabolic alterations similar to obesity. The associations of obesity held after adjustment for GDM and hypertensive disorders, but many of the associations with GDM and hypertensive disorders were rendered nonsignificant after adjustment for BMI and the other pregnancy disorders. CONCLUSIONS: This study shows that the pregnancy-related metabolic change is smaller in women with obesity, who display metabolic perturbations already in early pregnancy. Metabolic alterations of obesity and pregnancy disorders resembled each other suggesting a shared metabolic origin.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kivelä J, Sormunen-Harju H, Girchenko PV, et al. Longitudinal Metabolic Profiling of Maternal Obesity, Gestational Diabetes, and Hypertensive Pregnancy Disorders. J Clin Endocrinol Metab. 2021. PMID: 34185058. doi:10.1210/clinem/dgab475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。